Roman Gersner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roman Gersner has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Abraham Zangen
Department of Neurobiology, Weizmann Institute of Science Rehovot, Israel
1 shared publication - Abraham Zangen
Faculty of Life Sciences, Ben-Gurion University of the Negev, Be’er Sheva, Israel
1 shared publication - Alexander Rotenberg
Department of Neurology Boston Children's Hospital, Harvard Medical School Boston Massachusetts USA
1 shared publication Alvaro Pascual-Leone
1 shared publication- Limor Dinur Klein
Beer Ya'acov Mental Health Center, Beer Ya'acov, Israel
1 shared publication - Moshe Kotler
Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, P.O.B. 39040, Tel Aviv, 6139001, Israel
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by Springer Nature in Annals of General Psychiatry
- Vol. 11 (1) , 13
Deep transcranial magnetic stimulation add-on for the treatment of auditory hallucinations: a double-blind study
About 25% of schizophrenia patients with auditory hallucinations are refractory to pharmacotherapy and electroconvulsive therapy. We conducted a deep transcranial magnetic stimulation (TMS) pilot study in order to evaluate the potential clinical benefit of repeated left temporoparietal cortex stimulation in these patients. The results were encouraging, but a sham-controlled study was needed to rule out a placebo effect.
- 1 January 2012
- Published by Springer Nature in Annals of General Psychiatry
- Vol. 11 (1) , 13
Open AccessDeep transcranial magnetic stimulation add-on for the treatment of auditory hallucinations: a double-blind study
About 25% of schizophrenia patients with auditory hallucinations are refractory to pharmacotherapy and electroconvulsive therapy. We conducted a deep transcranial magnetic stimulation (TMS) pilot study in order to evaluate the potential clinical benefit of repeated left temporoparietal cortex stimulation in these patients. The results were encouraging, but a sham-controlled study was needed to rule out a placebo effect.